Consensus Lemonade, Inc.

Equities

LMND

US52567D1072

Market Closed - Nyse 16:00:02 2024-04-26 EDT 5-day change 1st Jan Change
17.95 USD +1.64% Intraday chart for Lemonade, Inc. +13.18% +11.28%

Evolution of the average Target Price on Lemonade, Inc.

Price target over the last 5 years

History of analyst recommendation changes

5c6ba5.peE52x87nAIXjHTOC4czKOG0POBhvKUB0vtU-bXNS_c.lYNK4mt8_zZ2yTyERdJXSaLOU9UVipVO5ZYgwMOeDpvdjQmcSWT-REfiGw~00e6b717ab93ec8e2bd97dd77c5e781c
Exchange-Traded Funds, Equity Futures Recover Pre-Bell Thursday to Continue Rate Cut-Fueled Rally MT
Morgan Stanley Adjusts Price Target on Lemonade to $12 From $11, Maintains Underweight Rating MT
Morgan Stanley Adjusts Price Target on Lemonade to $10 From $15, Maintains Underweight Rating MT
BMO Capital Adjusts Price Target on Lemonade to $9 From $8, Maintains Underperform Rating MT
Piper Sandler Adjusts Price Target on Lemonade to $17 From $18, Maintains Neutral Rating MT
Morgan Stanley Lifts Price Target on Lemonade to $15 From $14, Maintains Underweight Rating MT
Morgan Stanley Initiates Lemonade at Underweight With $14 Price Target, Says Stock Doesn't Reflect Long Path to Profitability MT
Barclays Adjusts Price Target on Lemonade to $17 From $16, Keeps Equalweight Rating MT
BofA Securities Adjusts Lemonade's Price Target to $12 From $14, Keeps Underperform Rating MT
Jefferies Cuts Price Target on Lemonade to $11.50 From $13, Maintains Underperform Rating MT
Piper Sandler Adjusts Price Target on Lemonade to $18 From $19, Maintains Neutral Rating MT
Barclays Adjusts Price Target on Lemonade to $16 From $18, Keeps Equalweight Rating MT
BMO Capital Initiates Coverage on Lemonade at Underperform With $10 Price Target MT
Piper Sandler Adjusts Price Target on Lemonade to $19 From $20, Maintains Neutral Rating MT
Keefe, Bruyette & Woods Initiates Coverage on Lemonade at Market Perform With $24 Price Target MT
Oppenheimer Adjusts Lemonade Price Target to $30 From $35, Maintains Outperform Rating MT
Piper Sandler Adjusts Price Target on Lemonade to $20 From $25, Maintains Neutral Rating MT
Barclays Adjusts Price Target on Lemonade to $18 From $28, Maintains Equal-Weight Rating MT
Oppenheimer Adjusts Lemonade Price Target to $35 From $30, Maintains Outperform Rating MT
Barclays Raises Lemonade's Price Target to $28 From $20, Maintains Equalweight Rating MT
Piper Sandler Adjusts Lemonade's Price Target to $25 From $20, Keeps Neutral Rating MT
Piper Sandler Downgrades Lemonade to Neutral From Overweight, Adjusts Price Target to $20 from $24 MT
Barclays Lowers Lemonade's Price Target to $20 From $22, Equalweight Rating Kept MT
JMP Securities Lowers Lemonade's Price Target to $40 From $95, Maintains Market Outperform Rating MT
Piper Sandler Adjusts Lemonade's Price Target to $24 from $32, Keeps Overweight Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
7
Last Close Price
17.95 USD
Average target price
18.83 USD
Spread / Average Target
+4.92%
High Price Target
40 USD
Spread / Highest target
+122.84%
Low Price Target
10 USD
Spread / Lowest Target
-44.29%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Lemonade, Inc.

Morgan Stanley
BMO Capital
Piper Sandler
Barclays
BofA Securities
Jefferies & Co.
Keefe, Bruyette & Woods
Oppenheimer
JMP Securities
Autonomous Research
Wolfe Research
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
  1. Stock Market
  2. Equities
  3. LMND Stock
  4. Consensus Lemonade, Inc.